MaxWell Biosystems

📍 Zurich, Switzerland🗓 Founded 2016👥 41 employees💰 Last funded Jun 2018
Biotechnology Research🌐 mxwbio.com
Website LinkedIn
Founded in September 2016 as an ETH Zürich spin-off, MaxWell Biosystems is a technology leader providing instrumentation and solutions to boost scientific research and development in neurosciences, stem cell and tissue engineering, ophthalmology, and other fields involving electrogenic cells. MaxOne (single-well) and MaxTwo (multi-well) are easy-to-use systems that equip scientists with the ability to record electrical signals of neurons in in-vitro 2D and 3D models at network, cellular, and subcellular levels. MaxWell Biosystems’ main goal is to be a trusted partner to all users and collaborators, for a greater cause, of advancing scientific breakthroughs and for achieving faster and more effective drug discovery, through our products, solutions, and expertise.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in MaxWell Biosystems?
MaxWell Biosystems has 1 investors on record on gritt.io, including 1 early-stage backers.
When did MaxWell Biosystems last raise funding?
The most recent investment in MaxWell Biosystems recorded on gritt.io was in June 2018.
When was MaxWell Biosystems founded?
MaxWell Biosystems was founded in 2016.
What industry is MaxWell Biosystems in?
MaxWell Biosystems operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is MaxWell Biosystems based?
MaxWell Biosystems is headquartered in Zurich, Switzerland.